Development of a scalable and robust AEX method for enriched rAAV preparations in genome-containing VCs of serotypes 5, 6, 8, and 9

Removal of empty capsids from adeno-associated virus (AAV) manufacturing lots remains a critical step in the downstream processing of AAV clinical-grade batches. Because of similar physico-chemical characteristics, the AAV capsid populations totally lacking or containing partial viral DNA are diffic...

Descripción completa

Detalles Bibliográficos
Autores principales: Joshi, Pranav R.H., Bernier, Alice, Moço, Pablo D., Schrag, Joseph, Chahal, Parminder S., Kamen, Amine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056178/
https://www.ncbi.nlm.nih.gov/pubmed/33898632
http://dx.doi.org/10.1016/j.omtm.2021.03.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056178/
https://www.ncbi.nlm.nih.gov/pubmed/33898632
http://dx.doi.org/10.1016/j.omtm.2021.03.016

Ejemplares similares